Sponsored by the National Malignancy Institute.

Adaptive radiotherapy may benefit individuals with head and neck cancer Researchers led by a senior investigator in Hofstra-North Shore LIJ School of Medication and The Feinstein Institute for Medical Study have released initial results from a first-of-a-kind clinical trial in adaptive radiotherapy for head and neck cancers. The trial, sponsored by the National Malignancy Institute, provides evidence that ART may benefit patients with less specialized problems than previously believed. The findings of the trial were released on-line in advance of publication in the International Journal of Radiation Oncology Biology Physics.The proposal has been met with a blistering attack from the American College of Radiology . [one provision] would require physicians to obtain prior authorization before purchasing expensive lab tests. The Medicare prior authorization plan would be pretty much modeled after programs that private insurers have increasingly plugged into their plans in recent years .org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an independent news service editorially, is a scheduled program of the Kaiser Family Foundation, a nonpartisan healthcare policy research company unaffiliated with Kaiser Permanente.

Kirsten Bibbins-Domingo, Ph.D., M.D., Glenn M.